You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLTX Sale Disclosure
Bodenstedt Matthias · SEC Form 4 · Filed Jun 18, 2026
Sale
Calculated transaction value
$296.81K
Bodenstedt Matthias Chief Financial Officer
Transaction date
Jun 17, 2026
Public filing date
Jun 18, 2026
Filing lag
Filed 1 day later
MLTX daily price context
Close on/before transaction
$19.19
Jun 17, 2026
First close after public filing
$22.16
Jun 22, 2026
30-day return after filing
-14.03%
Through Jul 20, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A ordinary shares, par value $0.0001 per share
- Quantity / price
- 15,082 shares @ $19.68
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001213900-26-070259
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$351.58K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moonlake Immunotherapeutics MLTX | Sale | Jun 18, 2026 | $54.76K |
| Moonlake Immunotherapeutics MLTX Current | Sale | Jun 17, 2026 | $296.81K |